# Microglia modulate stable wakefulness via the thalamic reticular nucleus in mice

**Authors:** Hanxiao Liu, Xinxing Wang, Lu Chen, Liang Chen, Stella E. Tsirka, Shaoyu Ge, Qiaojie Xiong

PMC · DOI: 10.1038/s41467-021-24915-x · Nature Communications · 2021-07-30

## TL;DR

Microglia help maintain stable wakefulness in mice by regulating ceramide levels in the thalamic reticular nucleus.

## Contribution

This study reveals a novel role of microglia in modulating wakefulness via ceramide signaling in the thalamic reticular nucleus.

## Key findings

- Microglial depletion disrupts stable nighttime wakefulness in mice.
- Ceramide levels in the brain correlate with sleep-wake behavior and are regulated by microglia.
- Activating TRN neurons or inhibiting ceramide production restores stable wakefulness in microglia-depleted mice.

## Abstract

Microglia are important for brain homeostasis and immunity, but their role in regulating vigilance remains unclear. We employed genetic, physiological, and metabolomic methods to examine microglial involvement in the regulation of wakefulness and sleep. Microglial depletion decreased stable nighttime wakefulness in mice by increasing transitions between wakefulness and non-rapid eye movement (NREM) sleep. Metabolomic analysis revealed that the sleep-wake behavior closely correlated with diurnal variation of the brain ceramide, which disappeared in microglia-depleted mice. Ceramide preferentially influenced microglia in the thalamic reticular nucleus (TRN), and local depletion of TRN microglia produced similar impaired wakefulness. Chemogenetic manipulations of anterior TRN neurons showed that they regulated transitions between wakefulness and NREM sleep. Their firing capacity was suppressed by both microglial depletion and added ceramide. In microglia-depleted mice, activating anterior TRN neurons or inhibiting ceramide production both restored stable wakefulness. These findings demonstrate that microglia can modulate stable wakefulness through anterior TRN neurons via ceramide signaling.

Here, the authors show that microglia depletion results in unstable wakefulness and altered levels of ceramide, influencing microglia in the mouse thalamic reticular nucleus (TRN). Stable wakefulness can be restored by activation of the TRN or inhibition of ceramide production in the mouse brain.

## Linked entities

- **Chemicals:** ceramide (PubChem CID 139583739)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Gad2 (glutamic acid decarboxylase 2) [NCBI Gene 14417] {aka 6330404F12Rik, GAD(65), GAD65, Gad-2}, RIC8B (RIC8 guanine nucleotide exchange factor B) [NCBI Gene 55188] {aka RIC8, hSyn}, Acer3 (alkaline ceramidase 3) [NCBI Gene 66190] {aka 1110057L18Rik, 5430429L08Rik, Phca, aPHC}, Mapk3 (mitogen-activated protein kinase 3) [NCBI Gene 26417] {aka Erk-1, Erk1, Ert2, Esrk1, Mnk1, Mtap2k}, Rbfox3 (RNA binding protein, fox-1 homolog (C. elegans) 3) [NCBI Gene 52897] {aka Fox-3, Hrnbp3, NeuN, Neuna60}, Asah1 (N-acylsphingosine amidohydrolase 1) [NCBI Gene 11886] {aka 2310081N20Rik, AC, Asah}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], Pvalb (parvalbumin) [NCBI Gene 19293] {aka PV, Parv, Pva}, CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Psmd1 (proteasome (prosome, macropain) 26S subunit, non-ATPase, 1) [NCBI Gene 70247] {aka 2410026J11Rik, P112, S1}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, S1pr2 (sphingosine-1-phosphate receptor 2) [NCBI Gene 14739] {aka 1100001A16Rik, Edg5, Gpcr13, H218, LPb2, S1P2}, Smpd3 (sphingomyelin phosphodiesterase 3, neutral) [NCBI Gene 58994] {aka 4631433G07Rik, Nsm2, fro, nSMase2}, AIF1 (allograft inflammatory factor 1) [NCBI Gene 199] {aka AIF-1, IBA1, IRT-1, IRT1}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580]
- **Diseases:** astrogliosis (MESH:D005911), neurodegenerative disease (MESH:D019636), CTX (MESH:D019294), Alzheimer's disease (MESH:D000544), injury (MESH:D014947), Wakefulness (MESH:D012893), eye movement (MESH:D015835), parasitic infections (MESH:D010272), neurological disorder (MESH:D009461), NREM sleep (MESH:D020923), Sleep deprivation (MESH:D012892), inflammation (MESH:D007249), TRN (MESH:D013786), DM (MESH:D009223), Car (MESH:C566176)
- **Species:** Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Mus musculus (house mouse, species) [taxon 10090], Adeno-associated virus (species) [taxon 272636], Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A2A
- **Cell lines:** TRN — Homo sapiens (Human), Transformed cell line (CVCL_T065)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8324895/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8324895/full.md

## References

103 references — full list in the complete paper: https://tomesphere.com/paper/PMC8324895/full.md

---
Source: https://tomesphere.com/paper/PMC8324895